Effects of combined use of ribociclib with PARP1 inhibitor on cell kinetics in breast cancer

In conclusion, the results obtained from cell kinetics parameters demonstrated the anticancer and antiproliferative effects of the combination of VLM and DPQ on breast cancer cells.PMID:38638847 | PMC:PMC11024784 | DOI:10.3892/ol.2024.14376
Source: Oncology Letters - Category: Cancer & Oncology Authors: Source Type: research